ArticleAmerican journal of cancer research2022
Nuclear moonlighting of the secreted growth factor heregulin drives endocrine-resistant breast cancer independently of HER2/HER3 signaling.
Lin Yang et al.PubMed ↗Full text ↗
No numbers read from the abstract.